Non-Lesional Filaggrin Expression May Predict Asthma in Kids With AD
Low filaggrin (FLG) expression in children aged 2 to 3 may predict of school-age asthma, according to new research slated to be presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting, in Washington, DC. In the study, pulmonary function testing (PFT) was conducted in 96 children, aged 7 to 8 years old, […]
Laser Hair Removal Helps Reduce Recurrence of Pilonidal Disease in Teens
Pilonidal disease is a painful inflammatory disease that occurs when cysts form between the buttocks. These cysts often recur following standard treatment with razors or creams. Peter C. Minneci, MD, Chair of Surgery at Nemours Children’s Health in Delaware Valley, recently conducted a study1 that looked at the use of laser hair removal in these patients. He […]
FDA Green Lights Leo’s Adbry for Kids With AD
The U.S. Food and Drug Administration (FDA) has expanded the approval of tralokinumab-ldrm (Adbry, LEO Pharma Inc) to include kids aged 12-17 years with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Adbry is the first and only FDA-approved biologic that specifically […]
Emergency Skin Issues in Peds
Dr. Kalyani Marathe discusses diagnosing, differentiating, and treating various pediatric dermatologic emergencies. Kalyani Marathe, MD, MPH, Director, Division of Dermatology and Associate Professor, University of Cincinnati, Department of Pediatrics So when we think about… rashes that are caused by infectious agents, there’s a pretty broad range, but some of the newer things that we’re seeing […]
Updates in Pediatric Dermatology
Dr. Lisa Swanson shares tips for treating children with common skin conditions, including updates on options for chronic skin problems. Lisa Swanson, MD, Ada West Dermatology, Boise, Idaho “I started my talk with some rapid-fire peds derm tips and began with using topical timolol to treat pyogenic granulomas. It’s very effective, very easy, and very […]
Treating Pediatric Hair Loss
Brittany Craiglow, MD, is Associate Professor Adjunct, Yale School of Medicine, New Haven, Connecticut. “It’s easy for people to… tell kids, ‘Oh, you can wear a hat or you can wear a wig, but it’s dramatically life altering for patients and families. There’s a huge impact on quality of life,” said Brittany Craiglow, MD, who […]
Predictors for PHACE Syndrome
Retrospective study provides evidence for risk stratification and timing of diagnostic work-up With Colleen Cotton, MD “Our retrospective study was conducted to identify predictors of a diagnosis of PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome in children with head and/or neck infantile hemangiomas (IH). Our findings indicate that children whose […]
Pediatric nonmelanoma skin cancer
With Jennifer Huang, MD Children without risk factors require vigilance “The general thinking in our specialty is that children who are otherwise healthy don’t get nonmelanoma skin cancers (NMSCs),” said Jennifer Huang, MD. “However, a study my colleagues and I published in the May issue of the Journal of the American Academy of Dermatology suggests […]
Pediatric Psoriasis: Characteristics of a Cohort at UCSF Spanning 2 Decades
With Kelly M. Cordoro, MD, and Carmel Aghdasi, BA Data presented at the Society for Pediatric Dermatology: 2021 Annual Meeting is helping to advance knowledge on epidemiology, clinical features, comorbidities, and evolving treatment patterns for pediatric psoriasis. In a retrospective cohort study of 754 psoriasis patients ages 0 to18 years seen at the University of […]
PEDIATRICS INFANTILE HEMANGIOMAS
Insights on ulcerated infantile hemangiomas in the ß-blocker era With Esteban Fernández-Faith, MD “Although ß-blockers have been standard therapy for problematic infantile hemangiomas (IHs) for a number of years, ulceration continues to be a challenge in many patients with IHs. Large studies of IH ulceration have not been performed since we started using ß-blockers,” said […]